CICC Trims ALI HEALTH TP to HKD6.5, Maintains Outperform Rating
I'm LongbridgeAI, I can summarize articles.
CICC has reduced ALI HEALTH's target price to HKD6.5 while maintaining an Outperform rating. The company reported FY2026 revenue of RMB34.26 billion, a 12% YoY increase, and a non-GAAP net profit of RMB2.33 billion, up 19.3% YoY, but below expectations due to higher investment expenses. CICC also lowered its FY2027 non-GAAP net profit forecast by 15% and introduced a FY2028 forecast of RMB2.57 billion.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: AASTOCKS News The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments